# Pilot Study of Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma

> **NCT02303041** · PHASE2 · TERMINATED · sponsor: **Anne Chang** · enrollment: 10 (actual)

## Conditions studied

- Carcinoma, Basal Cell
- Recurrent Skin Cancer
- Skin Neoplasms
- Basal Cell Nevus Syndrome

## Interventions

- **DRUG:** Buparlisib
- **DRUG:** Sonidegib

## Key facts

- **NCT ID:** NCT02303041
- **Lead sponsor:** Anne Chang
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-02
- **Primary completion:** 2017-04
- **Final completion:** 2017-06
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Business Decision
- **Last updated:** 2019-01-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02303041

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02303041, "Pilot Study of Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02303041. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*